Zika Virus Infection and Antibody Neutralization in FcRn Expressing Placenta and Engineered Cell Lines
As a developmental toxicant, Zika virus (ZIKV) attacks both the growing nervous system, causing congenital Zika syndrome, and the placenta, resulting in pathological changes and associated adverse fetal outcomes. There are no vaccines, antibodies, or other treatments for ZIKV, despite the potential...
Main Authors: | Yanqun Xu, Yong He, Sanaz Momben-Abolfath, Devin Vertrees, Xiaohong Li, Malgorzata G. Norton, Evi Budo Struble |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/12/2059 |
Similar Items
-
Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01) -
Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
by: Yanis Ramdani, et al.
Published: (2022-08-01) -
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
by: Tommy Li, et al.
Published: (2018-10-01) -
Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method
by: Thomas Müller, et al.
Published: (2023-12-01) -
Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
by: Yihan Zhou, et al.
Published: (2023-06-01)